维升药业-B盘中异动大幅上涨5.25%报39.700港元_老虎社区_美港股上老虎

维升药业-B盘中异动大幅上涨5.25%报39.700港元

市场透视01-26

2026年01月26日临近收盘15时52分，维升药业-B（02561.hk）股票出现异动，股价快速拉升5.25%。截至发稿，该股报39.700港元/股，成交量2.9万股，换手率0.03%，振幅5.25%。资金方面，该股资金流入83.2472万港元，流出19.8304万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-1.29亿港元，每股收益-1.29港元，毛利数据暂无，市盈率-22.98...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2606238102?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-26 15:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2606238102","market":"hk","top_or_hot":-1,"title":"维升药业-B盘中异动 大幅上涨5.25%报39.700港元","media":"市场透视","content":"<div>\n<p>2026年01月26日临近收盘15时52分，维升药业-B（02561.hk）股票出现异动，股价快速拉升5.25%。截至发稿，该股报39.700港元/股，成交量2.9万股，换手率0.03%，振幅5.25%。资金方面，该股资金流入83.2472万港元，流出19.8304万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-1.29亿港元，每股收益-1.29港元，毛利数据暂无，市盈率-22.98...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126155252a4569304&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>维升药业-B盘中异动 大幅上涨5.25%报39.700港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n维升药业-B盘中异动 大幅上涨5.25%报39.700港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-26 15:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126155252a4569304&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2026年01月26日临近收盘15时52分，维升药业-B（02561.hk）股票出现异动，股价快速拉升5.25%。截至发稿，该股报39.700港元/股，成交量2.9万股，换手率0.03%，振幅5.25%。资金方面，该股资金流入83.2472万港元，流出19.8304万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-1.29亿港元，每股收益-1.29港元，毛利数据暂无，市盈率-22.98...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126155252a4569304&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126155252a4569304&s=b","article_id":"2606238102","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126155252a4569304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606238102","pubTimestamp":1769413972,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2026年01月26日临近收盘15时52分，维升药业-B股票出现异动，股价快速拉升5.25%。截至发稿，该股报39.700港元/股，成交量2.9万股，换手率0.03%，振幅5.25%。资金方面，该股资金流入83.2472万港元，流出19.8304万港元。维升药业-B股票所在的生物技术行业中，整体跌幅为2.15%。其相关个股中，北海康成-B、维亚生物、中生北控生物科技涨幅较大，振幅较大的相关个股有北海康成-B、中生北控生物科技、维亚生物，振幅分别为19.48%、17.28%、15.35%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02561":"维昇药业-B"},"translate_title":"Weisheng Pharmaceutical-B intraday changes rose sharply 5.25% to HK $39.700","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02561":0.9},"content_text":"2026年01月26日临近收盘15时52分，维升药业-B（02561.hk）股票出现异动，股价快速拉升5.25%。截至发稿，该股报39.700港元/股，成交量2.9万股，换手率0.03%，振幅5.25%。资金方面，该股资金流入83.2472万港元，流出19.8304万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-1.29亿港元，每股收益-1.29港元，毛利数据暂无，市盈率-22.98倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维升药业-B股票所在的生物技术行业中，整体跌幅为2.15%。其相关个股中，北海康成-B、维亚生物、中生北控生物科技涨幅较大，振幅较大的相关个股有北海康成-B、中生北控生物科技、维亚生物，振幅分别为19.48%、17.28%、15.35%。维升药业-B公司简介：VISEN Pharmaceuticals是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。该公司的主要在研产品包括隆培促生长素、那韦培肽和帕罗培特立帕肽。隆培促生长素用于治疗3至17岁儿童生长激素缺乏症患者。那韦培肽是一款用于治疗2至10岁软骨发育不全儿童患者的疾病修复疗法。帕罗培特立帕肽是一款用于治疗成人甲状旁腺功能减退症的治疗方法。该公司处于研发后期、产品接近商业化。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}